医药前沿
醫藥前沿
의약전연
YIAYAO QIANYAN
2012年
33期
189-190
,共2页
幼儿%痰%肺炎链球菌%耐药性
幼兒%痰%肺炎鏈毬菌%耐藥性
유인%담%폐염련구균%내약성
children sputum%streptococcus pneumoniae%drug resistance
目的分析痰标本中肺炎链球菌的耐药状况,为临床合理用药提供依据.方法采用肺炎链球菌纸片扩散(K-B)法和MIC法检测82株肺炎链球菌耐药性,并做统计分析.结果肺炎链球菌对万古霉素、左氧氟沙星、头孢噻肟、奎奴普汀/达福普汀的敏感率分别为100%、90.24%、84.15%和80.49%,对红霉素、克林霉素、复方新诺明和青霉素的耐药率为97%、95.12%,91.46%和73.17%.结论肺炎链球菌对红霉素、克林霉素、复方新诺明和青霉素耐药,临床不能凭经验用药,应根据实验室结果合理用药.
目的分析痰標本中肺炎鏈毬菌的耐藥狀況,為臨床閤理用藥提供依據.方法採用肺炎鏈毬菌紙片擴散(K-B)法和MIC法檢測82株肺炎鏈毬菌耐藥性,併做統計分析.結果肺炎鏈毬菌對萬古黴素、左氧氟沙星、頭孢噻肟、奎奴普汀/達福普汀的敏感率分彆為100%、90.24%、84.15%和80.49%,對紅黴素、剋林黴素、複方新諾明和青黴素的耐藥率為97%、95.12%,91.46%和73.17%.結論肺炎鏈毬菌對紅黴素、剋林黴素、複方新諾明和青黴素耐藥,臨床不能憑經驗用藥,應根據實驗室結果閤理用藥.
목적분석담표본중폐염련구균적내약상황,위림상합리용약제공의거.방법채용폐염련구균지편확산(K-B)법화MIC법검측82주폐염련구균내약성,병주통계분석.결과폐염련구균대만고매소、좌양불사성、두포새우、규노보정/체복보정적민감솔분별위100%、90.24%、84.15%화80.49%,대홍매소、극림매소、복방신낙명화청매소적내약솔위97%、95.12%,91.46%화73.17%.결론폐염련구균대홍매소、극림매소、복방신낙명화청매소내약,림상불능빙경험용약,응근거실험실결과합리용약.
Object: Analysis resistance status of Streptococcus pneumoniae in sputum specimens, provided evidence for clinical rational drug use. Methods: Specimens were colected in 2010 at department of Clinical Laboratory in the Chengdu Women's and Children's Central Hospital. Results: Sensitivity of Streptococcus pneumoniae for Vancomycin, levofloxacin, cefotaxime, quinupristin/dalfopristin was 100%,90.24%,84.15% and 80.49%. Resistance rates of Streptococcus pneumoniae for erythromycin, clindamycin, cotrimoxazole, penicilin was 97%, 95.1%, 91.46% and 73.17%. Conclusions:Streptococcus pneumoniae was resisted for erythromycin, clindamycin, cotrimoxazole, penicilin, so clinical can not be use drug empiricaly, should be based on laboratory results.
